FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2017212631> ?p ?o ?g. }

• W2017212631 endingPage "540" @default.
• W2017212631 startingPage "534" @default.
• W2017212631 abstract "To assess whether therapy to achieve both a disease activity score in 28 joints (DAS28) less than 2.6 and matrix metalloproteinase (MMP) 3 normalisation offers better outcomes than either target alone in early rheumatoid arthritis (RA) at 56 weeks: Treating to Twin Targets (T-4) Study.243 early RA patients were randomly allocated to one of four strategy groups: routine care (R group; n=62); DAS28-driven therapy (D group; n=60); MMP-3-driven therapy (M group; n=60); or both DAS28 and MMP-3-driven therapy group (twin; T group; n=61). Medication was started with sulfasalazine (1 g/day) in all intervention groups. Targets were DAS28 less than 2.6 for the D group, MMP-3 normalisation for the M group and both DAS28 less than 2.6 and MMP-3 normalisation for the T group. If the value in question did not fall below the previously measured level, medication was intensified, including methotrexate, other disease-modifying antirheumatic drugs and biological agents. Primary, secondary and outcome measures consisted of the proportions of patients showing clinical remission (DAS28 <2.6), radiographic non-progression (Δmodified total Sharp score ≤0.5), normal physical function (modified health assessment questionnaire score 0), or comprehensive disease remission defined as the combination of clinical remission, radiographic non-progression and normal physical function.Clinical remission at 56 weeks was achieved by more patients in the T group (56%) than in the R group (p<0.0005) or M group (p<0.0005).Results of the T-4 Study reveal that a twin target strategy can achieve a high clinical remission rate in early RA." @default.
• W2017212631 created "2016-06-24" @default.
• W2017212631 creator A5003189262 @default.
• W2017212631 creator A5003482863 @default.
• W2017212631 creator A5013964702 @default.
• W2017212631 creator A5019415442 @default.
• W2017212631 creator A5066255291 @default.
• W2017212631 date "2011-10-21" @default.
• W2017212631 modified "2023-10-01" @default.
• W2017212631 title "Treating to target matrix metalloproteinase 3 normalisation together with disease activity score below 2.6 yields better effects than each alone in rheumatoid arthritis patients: T-4 Study" @default.
• W2017212631 cites W1994310131 @default.
• W2017212631 cites W1999084026 @default.
• W2017212631 cites W2000333164 @default.
• W2017212631 cites W2001917088 @default.
• W2017212631 cites W2002240106 @default.
• W2017212631 cites W2012620405 @default.
• W2017212631 cites W2037610923 @default.
• W2017212631 cites W2042620780 @default.
• W2017212631 cites W2080638211 @default.
• W2017212631 cites W2099334955 @default.
• W2017212631 cites W2106989209 @default.
• W2017212631 cites W2109237866 @default.
• W2017212631 cites W2111153776 @default.
• W2017212631 cites W2113674778 @default.
• W2017212631 cites W2121158586 @default.
• W2017212631 cites W2133038175 @default.
• W2017212631 cites W2134171514 @default.
• W2017212631 cites W2146166312 @default.
• W2017212631 cites W2147691195 @default.
• W2017212631 cites W2152348310 @default.
• W2017212631 cites W2153545348 @default.
• W2017212631 cites W2155109530 @default.
• W2017212631 cites W2156320332 @default.
• W2017212631 cites W2156712409 @default.
• W2017212631 cites W2157677292 @default.
• W2017212631 cites W2167660133 @default.
• W2017212631 cites W2169532722 @default.
• W2017212631 cites W2170660004 @default.
• W2017212631 cites W2418272246 @default.
• W2017212631 cites W2763284518 @default.
• W2017212631 cites W3006080604 @default.
• W2017212631 doi "https://doi.org/10.1136/annrheumdis-2011-200108" @default.
• W2017212631 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22021897" @default.
• W2017212631 hasPublicationYear "2011" @default.
• W2017212631 type Work @default.
• W2017212631 sameAs 2017212631 @default.
• W2017212631 citedByCount "38" @default.
• W2017212631 countsByYear W20172126312012 @default.
• W2017212631 countsByYear W20172126312013 @default.
• W2017212631 countsByYear W20172126312014 @default.
• W2017212631 countsByYear W20172126312015 @default.
• W2017212631 countsByYear W20172126312016 @default.
• W2017212631 countsByYear W20172126312017 @default.
• W2017212631 countsByYear W20172126312018 @default.
• W2017212631 countsByYear W20172126312019 @default.
• W2017212631 countsByYear W20172126312020 @default.
• W2017212631 countsByYear W20172126312021 @default.
• W2017212631 countsByYear W20172126312022 @default.
• W2017212631 countsByYear W20172126312023 @default.
• W2017212631 crossrefType "journal-article" @default.
• W2017212631 hasAuthorship W2017212631A5003189262 @default.
• W2017212631 hasAuthorship W2017212631A5003482863 @default.
• W2017212631 hasAuthorship W2017212631A5013964702 @default.
• W2017212631 hasAuthorship W2017212631A5019415442 @default.
• W2017212631 hasAuthorship W2017212631A5066255291 @default.
• W2017212631 hasConcept C126322002 @default.
• W2017212631 hasConcept C1862650 @default.
• W2017212631 hasConcept C2776999253 @default.
• W2017212631 hasConcept C2777575956 @default.
• W2017212631 hasConcept C2779134260 @default.
• W2017212631 hasConcept C2779383735 @default.
• W2017212631 hasConcept C2780479503 @default.
• W2017212631 hasConcept C2781059491 @default.
• W2017212631 hasConcept C71924100 @default.
• W2017212631 hasConcept C90924648 @default.
• W2017212631 hasConceptScore W2017212631C126322002 @default.
• W2017212631 hasConceptScore W2017212631C1862650 @default.
• W2017212631 hasConceptScore W2017212631C2776999253 @default.
• W2017212631 hasConceptScore W2017212631C2777575956 @default.
• W2017212631 hasConceptScore W2017212631C2779134260 @default.
• W2017212631 hasConceptScore W2017212631C2779383735 @default.
• W2017212631 hasConceptScore W2017212631C2780479503 @default.
• W2017212631 hasConceptScore W2017212631C2781059491 @default.
• W2017212631 hasConceptScore W2017212631C71924100 @default.
• W2017212631 hasConceptScore W2017212631C90924648 @default.
• W2017212631 hasIssue "4" @default.
• W2017212631 hasLocation W20172126311 @default.
• W2017212631 hasLocation W20172126312 @default.
• W2017212631 hasOpenAccess W2017212631 @default.
• W2017212631 hasPrimaryLocation W20172126311 @default.
• W2017212631 hasRelatedWork W148170575 @default.
• W2017212631 hasRelatedWork W2051823061 @default.
• W2017212631 hasRelatedWork W2262622611 @default.
• W2017212631 hasRelatedWork W2318634879 @default.
• W2017212631 hasRelatedWork W2320562573 @default.
• W2017212631 hasRelatedWork W2352009657 @default.
• W2017212631 hasRelatedWork W2352294526 @default.
• W2017212631 hasRelatedWork W2353992828 @default.

• next